Diffuse Large B-Cell Lymphoma News

News

Higher Treatment Dose Intensity Increases Infection Risk in Older Patients With DLBCL

05/06/2021

According to study findings, treatment with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone at an intended dose intensity of 80% or higher increased the risk of hospitalization for infection in a cohort of older...

According to study findings,...

05/06/2021

First Report Managed Care

News

New Options for DLBCL Treatment Will Likely Lead to Improved Outcomes

04/19/2021

In a new review article published online in Blood Cancer Journal, experts from the Lymphoma Research Foundation, Mayo Clinic Foundation, and Memorial Sloan-Kettering Cancer Center provide an in-depth review of new therapies recently approved...

In a new review article...

04/19/2021

First Report Managed Care

News

Encouraging Survival Rates With Treatment Regimen for High-Risk DLBCL

12/03/2020

“Outcomes for patients with high-risk DLBCL treated with R-CHOP chemotherapy are suboptimal but, to date, no alternative regimen has been shown to improve survival rates,” they wrote.

“Outcomes for patients with...

12/03/2020

First Report Managed Care

News

Reviewing a Cost-Effective Treatment Option for RR DLBCL

11/17/2020

Researchers recently examined the cost-effectiveness of a dual treatment among patients with transplant-ineligible relapsed/refractory diffuse large B-cell lymphoma.

Researchers recently examined...

11/17/2020

First Report Managed Care

News

Real-World Findings Question CAR-T Therapy’s Benefit Over Other Therapies for DLBCL

10/31/2020

“In the current study, we describe our single center experience treating patients with commercial CAR-T therapy for R/R DLBCL. We report response rates, PFS, and OS comparable to the pivotal trials and markedly better than outcomes seen in...

“In the current study, we...

10/31/2020

First Report Managed Care

News

Potential New Standard of Care Identified for Patients With DLBCL

10/19/2020

According to a study that looked at improving treatment for patients with diffuse large B-cell lymphoma, skipping radiation and receiving less chemotherapy may become the new standard of care.

According to a study that looked...

10/19/2020

First Report Managed Care

News

Survival Rates Among Patients With DLBCL, HIV Treated With Radiotherapy

10/05/2020

Researchers recently examined radiotherapy response differences among HIV positive patients who were also diagnosed with diffuse large B-cell lymphoma and found radiotherapy did not impact survival or progression in their limited sample.

Researchers recently examined...

10/05/2020

First Report Managed Care

News

Treatment Shows Promise for DLBCL

09/15/2020

“DLBCL, the most common type of aggressive non-Hodgkin lymphoma, has highly heterogeneous molecular characteristics. Although some patients initially respond to standard R–CHOP therapy, 30% to 40% develop refractory disease or suffer...

“DLBCL, the most common type of...

09/15/2020

First Report Managed Care

News

Predictive Model Gauges Likelihood of DLBCL Recurrence

09/08/2020

Scientists have created a predictive model to assess 2-year recurrence risk in patients with diffuse large B-cell lymphoma who have achieved remission.

Scientists have created a...

09/08/2020

First Report Managed Care

News

Low Vitamin D Common at Diagnosis With NHL-DLBCL, MM, and CLL

08/31/2020

"We observed low serum vitamin D levels in the majority of patients newly diagnosed with non-Hodgkin lymphoma/diffuse large B-cell lymphoma, chronic lymphocytic leukemia, and multiple myeloma," researchers recently found.

"We observed low serum vitamin D...

08/31/2020

First Report Managed Care

Current Issue

September 2024

Volume 21

Issue 3

Current Issue

Issue Archive

What's Trending?

News

Methotrexate Monotherapy vs Combination Therapy to Lower CV Risk in Early RA?

08/17/2016

As part of the TEAR trial, researchers studied the impact of methotrexate monotherapy or combination therapy with hydroxychloroquine plus sulfasalazine or in combination with etanercept on improving high-density lipoprotein (HDL) cholesterol...

As part of the TEAR trial,...

08/17/2016

First Report Managed Care

News

Medical Coding Creates Barriers to Care for Transgender Patients

09/13/2022

Helen Santoro ;

Many transgender patients in the United States are receiving coverage denials on gender-affirming care due in part to ICD-10 codes.

Many transgender patients in the...

09/13/2022

First Report Managed Care

Bilateral CI Shows Positive Effect on Language

03/16/2012

Eileen Koutnik-Fotopoulos ;

Results of a study on the effect of cochlear implantation (CI) on language development found that bilateral implantation was more advantageous than unilateral implantation in pediatric patients, according to findings reported in the Archives...

Results of a study on the effect...

03/16/2012

First Report Managed Care

News

U.S. Health Care System Unprepared for Major Nuclear Emergency

04/08/2011

First Report Managed Care

News

In Poll, Obama Is Given Trust Over Medicare

08/23/2012

First Report Managed Care

Video Insights

Videos

Bridging the Gaps in Prior Authorization: Challenges, Solutions, and Collaboration for Better Patient Care

11/13/2024

David Sand, MD, MBA, chief medical officer at ZeOmega, discusses the challenges of prior authorization, emphasizing the need for transparency, evidence-based standards, collaboration between payers and providers, and the potential for...

David Sand, MD, MBA, chief...

11/13/2024

First Report Managed Care

Videos

The Evolving Role of CGRP-targeting Therapies in Migraine Prevention

10/31/2024

Richard Lipton, MD, provides insights on the American Headache Society’s position statement update on calcitonin gene-related peptide (CGRP)-targeting therapies as a first-line option for the prevention of migraine.

Richard Lipton, MD, provides...

10/31/2024

First Report Managed Care

Videos

Unmet Needs in the Treatment and Management of Non–Small Cell Lung Cancer

09/26/2024

Alexander Spira , MD, PhD;

Alexander I. Spira, MD, PhD, discusses significant unmet needs in the treatment and management of non–small cell lung cancer (NSCLC).

Alexander I. Spira, MD, PhD,...

09/26/2024

First Report Managed Care

Videos

Treatment Options for NSCLC: A Discussion on Coverage, Clinical Outcomes, and Payer Perspectives

09/25/2024

Learn about research developments in 1L therapy for NSCLC patients with EGFR mutations and how outcomes may impact coverage and reimbursement decisions for insurers.

Learn about research...

09/25/2024

First Report Managed Care

Videos

Addressing the Root Cause of a Common Ocular Condition: A Virtual Roundtable

09/04/2024

View a roundtable discussion on Demodex blepharitis, a prevalent ocular condition that often goes undiagnosed in patients.

View a roundtable discussion on...

09/04/2024

First Report Managed Care

Videos

Addressing Health Disparities and Promoting Equity: The Role of Advanced Imaging Solutions

08/15/2024

Guest expert Jordan Bazinsky discusses the challenges facing the medical imaging industry, the potential of AI and emerging technologies, the role of advanced imaging solutions in promoting health equity, and the key trends and challenges...

Guest expert Jordan Bazinsky...

08/15/2024

First Report Managed Care

Videos

Promising Therapies and Clinical Trials for Chronic Lymphocytic Leukemia

08/14/2024

Farrukh T. Awan , MD;

Farrukh Awan, MD, highlights promising therapies and clinical trials within the field of chronic lymphocytic leukemia (CLL).

Farrukh Awan, MD, highlights...

08/14/2024

Journal of Clinical Pathways

Videos

Evolving Health Care Contact Centers Into Drivers of Value-Based Care

07/31/2024

Discover how health care contact centers can transform into drivers of value-based care through AI, automation, upskilling agents, and rethinking workflows and metrics to improve patient outcomes and population health.

Discover how health care contact...

07/31/2024

First Report Managed Care

Videos

Enhancing Patient Medication Adherence: Insights and Strategies From Asembia 2024

06/11/2024

Lucille Accetta, PharmD, MBA, MSPH, Senior Vice President of CVS Specialty Operations

Key stakeholders in the health care industry gathered to discuss prevalent topics at this year's Asembia annual summit. Medication adherence emerged as one of the most talked-about issues. In a session led by Lucille Accetta, PharmD, MBA,...

Key stakeholders in the health...

06/11/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Diffuse Large B-Cell Lymphoma News

Current Issue

What's Trending?

Video Insights

Subscribe to our eNewsletters!

Specialties

Events

Year Round Education

HMP Global Products